Compare Illumina, Inc. (ILMN) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Valero Energy Corporation — how do they compare? Illumina, Inc. trades at $181.14 (market cap $27.94B), while Valero Energy Corporation trades at $314.86 (market cap $93.03B). The key difference: Valero Energy Corporation is far larger — about 3.3× Illumina, Inc.'s market cap, and Valero Energy Corporation pays a 1.53% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | VLO | |
|---|---|---|
Market Cap | $27.94B | $93.03B |
Sector | Health | Energy |
52-Week High | $194.33 | $313.31 |
52-Week Low | $91.00 | $131.77 |
Enterprise Value | $29.33B | $98.79B |
Dividend Yield | — | 1.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Valero Energy (VLO) trades at $314.81, up 1.67% on the day, with strong technical momentum and bullish moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $4.22 surpassing expectations of $3.16. Revenue declined to $122.69 billion in 2025, but net income margin held at 3.37%, supported by robust refining margins. Recent news highlights strong fuel demand and elevated crack spreads benefiting Valero's outlook.
The outlook remains positive given earnings beats, analyst buy ratings (55.55%), and refining margin tailwinds. However, declining revenue trends, high RSI levels suggesting overbought conditions, and exposure to volatile energy markets pose risks. The consensus price target of $276.22 implies potential downside from current levels, requiring careful monitoring of Q2 2026 earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
